Berlin - Delayed Quote EUR

Ocean Biomedical Inc (8AW0.BE)

Compare
0.1810
0.0000
(0.00%)
As of 9:10:10 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
1,385.0000
10,214.0000
16,121.0000
62,345.0000
1,652.0000
Operating Income
-1,385.0000
-10,214.0000
-16,121.0000
-62,345.0000
-1,652.0000
Net Non Operating Interest Income Expense
-2,113.0000
-1,762.0000
-1,243.0000
--
--
Other Income Expense
-23,121.0000
-102,490.0000
5.0000
1.0000
-1.0000
Pretax Income
-26,619.0000
-114,466.0000
-17,359.0000
-62,344.0000
-1,653.0000
Net Income Common Stockholders
-26,619.0000
-114,466.0000
-17,359.0000
-62,344.0000
-1,653.0000
Diluted NI Available to Com Stockholders
-26,619.0000
-114,466.0000
-17,359.0000
-62,344.0000
-1,653.0000
Basic EPS
-0.95
-4.35
-0.86
-3.09
-0.08
Diluted EPS
-0.95
-4.35
-0.86
-3.09
-0.08
Basic Average Shares
27,392.3700
26,292.4380
36,496.4130
20,203.4400
20,203.4400
Diluted Average Shares
27,392.3700
26,292.4380
36,496.4130
20,203.4400
20,203.4400
Total Operating Income as Reported
-1,385.0000
-10,214.0000
-16,121.0000
-62,345.0000
-1,652.0000
Total Expenses
1,385.0000
10,214.0000
16,121.0000
62,345.0000
1,652.0000
Net Income from Continuing & Discontinued Operation
-26,619.0000
-114,466.0000
-17,359.0000
-62,344.0000
-1,653.0000
Normalized Income
-8,141.0000
-14,202.0000
-17,359.0000
-62,344.0000
-1,653.0000
Interest Income
--
--
1,523.9000
--
--
Interest Expense
2,113.0000
1,762.0000
1,243.0000
--
--
Net Interest Income
-2,113.0000
-1,762.0000
-1,243.0000
--
--
EBIT
-24,506.0000
-112,704.0000
-16,116.0000
-62,345.0000
-1,652.0000
EBITDA
-24,506.0000
-112,704.0000
-16,116.0000
-62,345.0000
-1,652.0000
Net Income from Continuing Operation Net Minority Interest
-26,619.0000
-114,466.0000
-17,359.0000
-62,344.0000
-1,653.0000
Total Unusual Items Excluding Goodwill
-18,478.0000
-100,264.0000
--
--
--
Total Unusual Items
-18,478.0000
-100,264.0000
--
--
--
Normalized EBITDA
-6,028.0000
-12,440.0000
-16,116.0000
-62,345.0000
-1,652.0000
12/31/2020 - 11/3/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1VT.DU Viking Therapeutics Inc
32.57
+1.31%
 
2UV.F Applied Therapeutics, Inc.
0.5465
+6.12%
 
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
 
0M4.DU Mersana Therapeutics Inc
0.6036
+2.20%
 
NV4.MU Cellectar Biosciences Inc
0.2420
0.00%
 
3G0.BE Altimmune Inc
6.70
-0.21%
 
M55.F MacroGenics, Inc.
2.8800
-0.48%
 
2UV.DU Applied Therapeutics Inc
0.5570
-3.05%
 
AT20.F Atara Biotherapeutics, Inc.
8.05
+8.05%
 
3G0.MU Altimmune Inc
6.67
+0.68%